| There are a number of trends taking place lately in | | | | any prescription medicine they may need. When |
| the pharmaceutical industry, one of them being | | | | these big pharmaceutical companies take away this |
| generic drugs, the other being globalization of generic | | | | option to buy generic medicine, this puts the burden |
| medicine. As generic medicine is taken root in smaller, | | | | directly on the consumers and the employers who |
| less developed countries, the big pharmaceutical | | | | provide health care for their employees. Because |
| companies are clamoring for a piece of the action. | | | | brand name medicine can be so expensive this is |
| With generic medicine on the rise in the U.S. and | | | | resulting in thousands of businesses dropping health |
| abroad, some big pharmaceutical companies have | | | | care plans for their employees altogether, putting a |
| turned to underhanded practices to get these | | | | huge financial burden back onto consumers, often |
| cheaper drugs out of the market. Big pharmaceutical | | | | resulting in them not being able to afford any kind of |
| companies are now paying off smaller generic drug | | | | medicine altogether. |
| makers to halt production altogether, to keep these | | | | Because of these recent practices by the large |
| cheaper drugs out of the market. But who pays the | | | | branded drug companies to keep any competition |
| price for this in the end? | | | | out, many other recipients who are not involved are |
| In recent years larger brand name pharmaceutical | | | | being affected as well. Many pharmaceutical sales |
| companies have started the practice of entering into | | | | consulting firms, who work hard to keep an eye on |
| agreements with smaller generic drug companies, to | | | | these recent developments, have noticed something |
| slow down production of their generic drugs, or halt | | | | even more alarming. They are noticing that as many |
| production altogether. Up until recently, big | | | | large branded companies take away the option of |
| pharmaceutical companies have tried to work hand in | | | | buying generic medicine, taxpayers are footing most |
| hand with smaller generic drug companies over | | | | of the bill. Because many individuals have no way of |
| licensing rights to drugs and even making generic | | | | affording these expensive brand named medicines |
| brand named medicine. Even though this seems like | | | | many people are turning to their governments for |
| an effective strategy, some of the more | | | | assistance. As the governments of the world are |
| underhanded dealings by the big pharmaceutical | | | | taking on more and more people to cover their |
| companies may not be good for everyone. | | | | health insurance plans, the cost is going back to the |
| The cost of the average generic drug can be | | | | taxpayer. In the end nobody wins but the large |
| anywhere from 60% to 80% of the brand name | | | | pharmaceutical company. |
| alternative. But it's not just the individuals that are | | | | If you enjoyed this article, please feel free to post it |
| hurting from these underhanded practices. Lower | | | | to your site or blog and forward this link to your |
| drug prices also benefit businesses as well as many | | | | friends. Have a great day! |
| employers pay for their workers' health care, including | | | | Don't forget to visit our blog. |